BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 34161675)

  • 21. Silencing of tumor-suppressive NR_023387 in renal cell carcinoma via promoter hypermethylation and HNF4A deficiency.
    Zhou H; Guo L; Yao W; Shi R; Yu G; Xu H; Ye Z
    J Cell Physiol; 2020 Mar; 235(3):2113-2128. PubMed ID: 31432508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma.
    Wang L; Fan Y; Zhang L; Li L; Kuang G; Luo C; Li C; Xiang T; Tao Q; Zhang Q; Ying J
    FASEB J; 2019 Jan; 33(1):254-263. PubMed ID: 29957056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Influence of Oncogenic Viruses in Renal Carcinogenesis: Pros and Cons.
    Manole B; Damian C; Giusca SE; Caruntu ID; Porumb-Andrese E; Lunca C; Dorneanu OS; Iancu LS; Ursu RG
    Pathogens; 2022 Jul; 11(7):. PubMed ID: 35890003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic silencing of ZBTB28 promotes renal cell carcinogenesis.
    Tong X; Xu L; Rong R; Su X; Xiang T; Peng W; Shi T
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e79-e86. PubMed ID: 34161675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and epigenetic alterations during renal carcinogenesis.
    Arai E; Kanai Y
    Int J Clin Exp Pathol; 2010 Dec; 4(1):58-73. PubMed ID: 21228928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Overview of Epigenetics in Clear Cell Renal Cell Carcinoma.
    Grammatikaki S; Katifelis H; Farooqi AA; Stravodimos K; Karamouzis MV; Souliotis K; Varvaras D; Gazouli M
    In Vivo; 2023; 37(1):1-10. PubMed ID: 36593023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of DNA Methylation in Renal Cell Carcinoma.
    Lasseigne BN; Brooks JD
    Mol Diagn Ther; 2018 Aug; 22(4):431-442. PubMed ID: 29777398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetics in advanced renal cell carcinoma: Potential new targets.
    Molina-Cerrillo J; Santoni M; Ruiz Á; Massari F; Pozas J; Ortego I; Gómez V; Grande E; Alonso-Gordoa T
    Crit Rev Oncol Hematol; 2022 Dec; 180():103857. PubMed ID: 36257538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma.
    Lameirinhas A; Miranda-Gonçalves V; Henrique R; Jerónimo C
    Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30986931
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.